The challenge of antiplatelet therapy in patients with atrial fibrillation and heart failure.

about

Advances in induced pluripotent stem cells, genomics, biomarkers, and antiplatelet therapy highlights of the year in JCTR 2013.

P2860

Q30359241-D08001D5-3FB1-4023-B9A5-05612CA83434

P2860

The challenge of antiplatelet therapy in patients with atrial fibrillation and heart failure.

Item

http://www.wikidata.org/entity/Q38064758

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

The challenge of antiplatelet ...... ibrillation and heart failure.

@en

type

Item

label

The challenge of antiplatelet ...... ibrillation and heart failure.

@en

prefLabel

The challenge of antiplatelet ...... ibrillation and heart failure.

@en

P1476

The challenge of antiplatelet ...... ibrillation and heart failure.

@en

P2093

Stavros Apostolakis

http://www.w3.org/2001/XMLSchema#string

Yutao Guo

http://www.w3.org/2001/XMLSchema#string

P2860

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)

Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure

Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: a randomized multicenter study

Low-dose aspirin for prevention of stroke in low-risk patients with atrial fibrillation: Japan Atrial Fibrillation Stroke Trial

A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO)

Efficacy of antithrombotic therapy in chronic heart failure: the HELAS study

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial

P2888

s12265-012-9427-y

P304

388-397

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1007/S12265-012-9427-Y

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gregory Y. H. Lip

P577

2012-12-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1010073537

http://www.w3.org/2001/XMLSchema#string

P698

23208014

http://www.w3.org/2001/XMLSchema#string

The challenge of antiplatelet therapy in patients with atrial fibrillation and heart failure.

about

P2860

P2860

The challenge of antiplatelet therapy in patients with atrial fibrillation and heart failure.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698